MARKET

ASRT

ASRT

Assertio Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7122
-0.0018
-0.25%
After Hours: 0.6910 -0.0212 -2.98% 18:44 10/20 EDT
OPEN
0.7150
PREV CLOSE
0.7140
HIGH
0.7563
LOW
0.7120
VOLUME
192.57K
TURNOVER
--
52 WEEK HIGH
1.710
52 WEEK LOW
0.5500
MARKET CAP
76.29M
P/E (TTM)
-0.3382
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Maple Leaf Foods Makes History with One Year of Carbon Neutrality
Maple Leaf Foods Inc. (TSX: MFI), a leading North American producer of high-quality, sustainable meat and plant-based proteins, will mark one year as a carbon neutral company November 7, 2020, a significant milestone in the organization's purposeful journey to become the most sustainable protein company on earth.
PR Newswire · 17h ago
Why Assertio Holdings (ASRT) Stock is a Compelling Investment Case
Summers Value Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of -1.2% in the first nine months of 2020, outperforming its benchmark, the Russell 2000 Index which returned -9.6% in the same period. You should check out Summers Value Partners’ top 5 […]
Insider Monkey · 1d ago
Summers Value Partners Q3 2020 Investor Letter
Summers Value Partners is a boutique value manager that uses a focused, long-term approach to investing in areas of the market where most managers are unwilling or unable to participate.The Summers Value Fund LP declined by 1.2% net during the first nine months of 2020, outpacing the Russell 2000 Index return of -9.6% and the Russell Microcap Index return of -9.1%.Our shorting activities continue to be limited as we wait for better opportunities. The Fund has generated a small loss on the short side year-to-date.We currently have more ideas than we do capital. We added two new positions in the third quarter, and our idea funnel remains full.
Seekingalpha · 5d ago
Is Assertio Holdings, Inc. (ASRT) A Good Stock To Buy?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]
Insider Monkey · 6d ago
Media Advisory - Maple Leaf Foods Inc. 2020 Third Quarter Financial Results Conference Call
TSX: MFI www.mapleleaffoods.
CNW Group · 6d ago
Media Advisory - Prime Minister's itinerary for Tuesday, October 13, 2020
OTTAWA, ON, Oct. 12, 2020 /CNW/ -Note: All times localOttawa, Ontario Private meetings.
CNW Group · 10/13 01:27
Australis Capital Announces Management and Board Changes
LAS VEGAS, Nev., Oct.
CNW Group · 10/05 12:30
Field Roast's Chao Creamery Expands Dairy-Free Cheese Portfolio With Five New Varieties
Field Roast, the maker of the 1 selling plant-based cheese slice variety in U.S. retail, introduced 5 new dairy-free cheese flavors and forms.
Business Wire · 09/15 13:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ASRT. Analyze the recent business situations of Assertio Therapeutics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ASRT stock price target is 2.475 with a high estimate of 3.500 and a low estimate of 1.450.
EPS
Institutional Holdings
Institutions: 203
Institutional Holdings: 52.97M
% Owned: 49.45%
Shares Outstanding: 107.12M
TypeInstitutionsShares
Increased
16
3.55M
New
50
3.32M
Decreased
32
9.68M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.01%
Pharmaceuticals & Medical Research
-0.26%
Key Executives
Chairman/Independent Director
James Fogarty
President/Chief Executive Officer/Director
Arthur Higgins
Chief Financial Officer/Senior Vice President
Daniel Peisert
Senior Vice President/Chief Technology Officer/Chief Scientific Officer
Stanley Bukofzer
Senior Vice President/Director of Human Resources
Sharon Larkin
Independent Director
Karen Dawes
Senior Vice President
Stan Bukofzer
Independent Director
James Galeota
Senior Vice President
Gerd Kochendoerfer
Independent Director
Heather Mason
Independent Director
William McKee
Independent Director
Peter Staple
Independent Director
James Tyree
Independent Director
Gavin Molinelli
Independent Director
David Wheadon
Independent Director
Robert Savage
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ASRT
Assertio Holdings, Inc. is a specialty pharmaceutical company. The Company owns a portfolio of prescription neurology, inflammation and pain medications. Its marketed products include Cambia (diclofenac potassium) for Oral solution, INDOCIN Oral Suspension, INDOCIN (indomethacin) Suppositories, OXAYDO tablets, SPRIX Nasal Spray, VIVLODEX capsules, ZIPSOR Liquid filled capsules and ZORVOLEX capsules. The Company is also focused on developing and commercializing neurology, orphan and specialty medicines. Its pipeline products include Diclofenac Potassium, Long-acting Cosyntropin and Diclofenac potassium. Diclofenac Potassium is being developed for mild/moderate acute pain. Long-acting Cosyntropin is being developed for diagnosis of adrenal insufficiency. Diclofenac potassium is a liquid formulation being developed for acute migraine attacks.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Assertio Holdings Inc stock information, including NASDAQ:ASRT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASRT stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ASRT stock methods without spending real money on the virtual paper trading platform.